The interplay between lipid metabolism, autonomic nervous system function, and myocardial electrophysiology is increasingly recognized as a relevant factor in patients with bradyarrhythmias or pacing systems. Very low levels of high-density lipoprotein (HDL), heightened parasympathetic activity, and changes in myocardial excitability may converge to influence cardiac pacing thresholds and arrhythmogenic potential.
Low HDL levels have been consistently associated with impaired autonomic modulation, particularly reduced parasympathetic (vagal) tone, as evidenced by decreased heart rate variability (HRV). HDL promotes endothelial nitric oxide (NO) production, modulates inflammatory pathways, and maintains baroreceptor sensitivity—factors integral to vagal efficacy. A deficiency in HDL may blunt these mechanisms, impairing vagal responsiveness and predisposing to autonomic imbalance.
HDL plays a regulatory role in myocardial ion homeostasis and cellular excitability:
Vagal stimulation exerts a depressant effect on cardiac excitability, particularly within atrial tissue. Acetylcholine released via parasympathetic fibers increases action potential thresholds, prolongs refractory periods, and suppresses sinus node activity. In ventricular myocardium, this can synergize with any preexisting substrate abnormalities to lower excitability and increase pacing thresholds—especially during sleep or periods of increased vagal tone.
In patients with leadless pacemakers, particularly those with:
...this triad may represent a non-structural yet physiologically significant cause of nocturnal capture failure. Mechanisms may include:
Very low HDL may contribute to autonomic dysregulation and altered myocardial excitability. In the context of increased parasympathetic tone, particularly during nocturnal periods, these factors can synergistically impair the performance of a leadless pacemaker by raising capture thresholds and destabilizing ventricular depolarization. Consideration of metabolic and autonomic status may be warranted when evaluating unexplained variations in pacing performance, especially in patients with low HDL and vagal dominance.